Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes
about
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domainsHepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domainReliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virusA role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell lineArbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infectionA new insight into hepatitis C vaccine developmentMechanisms of viral entry: sneaking in the front doorStrategies to reduce hepatitis C virus recurrence after liver transplantationVaccination for hepatitis C virus: closing in on an evasive targetCellular cofactors affecting hepatitis C virus infection and replicationEntry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptorHepatitis C virus proteinsUnbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infectionThe tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virusBiochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidolScavenger receptor BI and BII expression levels modulate hepatitis C virus infectivityInitiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type IClaudin-6 and claudin-9 function as additional coreceptors for hepatitis C virusFirst Dominique Dormont International Conference on "Host-pathogen interactions in chronic infections - viral and host determinants of HCV, HCMV, and HIV infections"Roles of lipoprotein receptors in the entry of hepatitis C virusGenetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignNew hepatitis C virus drug discovery strategies and model systemsAutophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseasesT cell responses in hepatitis C virus infection: historical overview and goals for future researchThe hepatitis C virus glycan shield and evasion of the humoral immune responseNeutralizing antibody response to hepatitis C virusMolecular determinants and dynamics of hepatitis C virus secretionEffect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host TargetsIn Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus GenotypesScavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infectionAn Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing AntibodiesRole of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins.Robust hepatitis C virus infection in vitro.Stimulation of hepatitis C virus (HCV) nonstructural protein 3 (NS3) helicase activity by the NS3 protease domain and by HCV RNA-dependent RNA polymeraseEfficient hepatitis C virus cell culture system: what a difference the host cell makes.Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope GlycoproteinAnalysis of a Highly Flexible Conformational Immunogenic Domain A in Hepatitis C Virus E2Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.
P2860
Q21089621-C99D4781-7439-41D8-B87C-BB658A8A4EB8Q21090524-B350D56E-FEFB-464D-A490-C266319AF6D8Q21090530-374EA8DE-1E92-4CE2-A5B2-A44611958327Q21245053-B3CA2D63-EDB5-4022-8ED8-B3B5C5C09440Q21245138-BC2ECD1F-009B-4F9F-A9F0-3776B026D120Q21296858-AFDB8078-831F-4F74-A678-57D77A606623Q22252690-65FF9896-7C85-43FD-9A30-82D81A607F67Q22305418-F62A74AA-9C69-4543-8D55-2D564EFE98EFQ22305922-220E2836-43EE-4BC6-885C-4E956F9E888FQ24317564-FA2A35DB-7486-4EF4-879F-D4B53D0A0E33Q24336433-1BAB6148-3077-4901-A177-4F965E5C5281Q24563969-775347B8-D1FA-430F-BDAC-457C72AD14C5Q24646403-16F38D0C-E70F-41CD-91DE-320A05984D3DQ24652906-0C7CDD75-A560-4420-A7C3-797CFCDC0833Q24653452-1EB7E6F0-2812-442F-A2E4-5E934E31352BQ24672232-95446027-2920-4918-B7E1-74F74D5B2D04Q24676039-E8863D63-8A3B-4A8E-A802-C19B35B7A6C8Q24681592-3AFF3667-5655-4A96-91DD-DDFA9D0303CCQ24795522-D6BEAD23-3089-43D2-8468-E3037690A8ABQ26777338-5C6B8071-D431-4666-9902-3FB61BD7DCFEQ26801759-A9677CD2-C2CC-4FC9-887D-945F35153314Q26851159-A331DA61-7DF0-4C9F-B47B-F2C468D83722Q26992256-466A22F5-AD6C-4BA2-BE5E-B0CDA465C973Q27003510-FC6CDEBA-4902-4114-95AA-62F29BD7E59CQ27023390-B4F33D38-F663-413A-84D3-2FCEF6E7B594Q27027484-545E114D-0B75-443B-88C8-C52632829267Q27347838-CEEDB596-5507-4DE8-B92A-2A052700BFCAQ27468855-7A7BE913-B294-443D-852B-C9BB9A9064ACQ27468929-4E8EED76-525E-4A39-81E9-6EFA435C8415Q27469468-3B069C71-5384-4F33-A0D3-ECF33262E490Q27469507-5C5F6A3D-32FE-480B-A0C8-DEDEFF9796F5Q27469837-D2AEEC95-6F31-4BE2-A321-D7453ACB1E01Q27469844-20EBDC27-4390-4146-B0C6-B96B892CFCC4Q27470013-DFE7EBAF-C617-4690-8C93-11276DDDF07DQ27470016-1842C6BF-94A1-47E1-9AC8-D52D296525D1Q27470192-32ACFADC-4C8F-4540-BE5D-4D57F958DD75Q27470798-BEC6A1D8-9BFD-492D-9201-0874D1C47747Q27472672-9BDC14A7-3A9F-4352-99C3-4358EF0FDF84Q27472707-C2245344-DF88-4059-8A71-975F8326EC99Q27472768-41CABB67-99F8-4392-B179-2064909541A3
P2860
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Infectious hepatitis C virus p ...... -E2 envelope protein complexes
@ast
Infectious hepatitis C virus p ...... -E2 envelope protein complexes
@en
Infectious hepatitis C virus p ...... -E2 envelope protein complexes
@nl
type
label
Infectious hepatitis C virus p ...... -E2 envelope protein complexes
@ast
Infectious hepatitis C virus p ...... -E2 envelope protein complexes
@en
Infectious hepatitis C virus p ...... -E2 envelope protein complexes
@nl
altLabel
Infectious Hepatitis C Virus P ...... –E2 Envelope Protein Complexes
@en
prefLabel
Infectious hepatitis C virus p ...... -E2 envelope protein complexes
@ast
Infectious hepatitis C virus p ...... -E2 envelope protein complexes
@en
Infectious hepatitis C virus p ...... -E2 envelope protein complexes
@nl
P2860
P50
P3181
P356
P1476
Infectious hepatitis C virus p ...... -E2 envelope protein complexes
@en
P2860
P304
P3181
P356
10.1084/JEM.20021756
P407
P577
2003-03-01T00:00:00Z